ClinicalTrials.Veeva

Menu

Telerehabilitation in Mild Cognitive Impairment

I

IRCCS Centro San Giovanni di Dio Fatebenefratelli

Status

Completed

Conditions

Mild Cognitive Impairment

Treatments

Behavioral: Face to Face VRRS plus active tDCS and telerehabilitation
Behavioral: Usual rehabilitation program
Behavioral: Face to Face VRRS and telerehabilitation
Behavioral: FTF VRRS plus unstructured CS
Behavioral: Face to Face VRRS plus placebo tDCS and telerehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT03486704
VR-Rehab-MCI

Details and patient eligibility

About

The main aim of the study is to evaluate the efficacy of the Virtual Reality Rehabilitation System (VRRS) compared to usual care treatment for patients with Mild Cognitive Impairment (MCI). Moreover, we will assess the possibility to prolong the beneficial effects of the treatment with an innovative telerehabilitation system. In the second phase of the present study we aim to evaluate the short and long term effects induced by the treatment of active (anodal) transcranial Direct Current Stimulation (tDCS) applied to the left dorsolateral prefrontal cortex combined with VRRS compared to placebo tDCS stimulation combined with VRRS.

The effects of the intervention on outcome variables will be assessed using a randomized controlled trial design with five groups. The investigators will assess the effects of VRRS system and of the implementation of the at-home treatment on the quality of life, cognitive and functional abilities.

Enrollment

109 patients

Sex

All

Ages

60 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of MCI, defined according to standard criteria (Petersen et al., 2011)
  • Mini Mental State Examination (MMSE) ≥24
  • Education ≥ 5 years
  • All of the subjects will have normal or corrected-to-normal vision and will be native Italian speakers.
  • All participants reported subjective memory complaints and objective memory impairment, but no impairment of function in daily life.

Exclusion criteria

  • visual perception disorder and/or hearing loss
  • history of major psychiatric disorders
  • any contraindication for tDCS such as a history of seizures, major head trauma, past brain surgery, a brain metal implant or a pacemaker.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

109 participants in 5 patient groups

Face to Face VRRS and telerehabilitation
Experimental group
Description:
Participants will receive 12 sessions of an individualized Face to Face cognitive training using VRRS over 4 weeks followed by 36 sessions of home-based VRRS cognitive training, three sessions for week.
Treatment:
Behavioral: Face to Face VRRS and telerehabilitation
Usual rehabilitation program
Active Comparator group
Description:
The usual rehabilitation group will receive 12 sessions of face-to-face usual cognitive training program.
Treatment:
Behavioral: Usual rehabilitation program
FTF VRRS plus unstructured CS
Active Comparator group
Description:
Participants will receive 12 sessions of an individualized Face to Face (FTF) cognitive training using VRRS over 4 weeks followed by 36 sessions of home-based unstructured cognitive stimulation (CS), three sessions for week.
Treatment:
Behavioral: FTF VRRS plus unstructured CS
Face to Face VRRS plus active tDCS and telerehabilitation
Experimental group
Description:
Participants will receive 12 sessions of an individualized Face to Face cognitive training using VRRS combined with active (anodal) tDCS applied to the left dorsolateral prefrontal cortex over 4 weeks followed by 36 sessions of home-based VRRS cognitive training, three sessions for week.
Treatment:
Behavioral: Face to Face VRRS plus active tDCS and telerehabilitation
Face to Face VRRS plus placebo tDCS and telerehabilitation
Active Comparator group
Description:
Participants will receive 12 sessions of an individualized Face to Face cognitive training using VRRS combined with placebo tDCS applied to the dorsolateral prefrontal cortex of the left hemisphere over 4 weeks followed by 36 sessions of home-based VRRS cognitive training, three sessions for week.
Treatment:
Behavioral: Face to Face VRRS plus placebo tDCS and telerehabilitation

Trial contacts and locations

1

Loading...

Central trial contact

Maria Cotelli, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems